Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

about

Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.

P2860

Q33638001-2268931E-589C-45AD-A529-ACE57D27CF6A

P2860

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

Item

http://www.wikidata.org/entity/Q40688534

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rilpivirine resistance mutatio ...... evalent polymorphic mutations.

@en

type

Item

label

Rilpivirine resistance mutatio ...... evalent polymorphic mutations.

@en

prefLabel

Rilpivirine resistance mutatio ...... evalent polymorphic mutations.

@en

P1476

Rilpivirine resistance mutatio ...... evalent polymorphic mutations.

@en

P2093

Atsuko Hachiya

http://www.w3.org/2001/XMLSchema#string

Hirotaka Ode

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Gatanaga

http://www.w3.org/2001/XMLSchema#string

Masafumi Takiguchi

http://www.w3.org/2001/XMLSchema#string

Shinichi Oka

http://www.w3.org/2001/XMLSchema#string

Takeshi Nishijima

http://www.w3.org/2001/XMLSchema#string

Tsunefusa Hayashida

http://www.w3.org/2001/XMLSchema#string

Wataru Sugiura

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.

Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity

DNA deamination mediates innate immunity to retroviral infection

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.

HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.

Adaptation of HIV-1 to human leukocyte antigen class I

Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.

Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors.

P304

2760-2766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW224

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kiyoto Tsuchiya

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27330069

http://www.w3.org/2001/XMLSchema#string

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

about

P2860

P2860

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698